New York, NY, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Plasma Fractionation Market Share, Size, Trends, Industry Analysis Report, By Product (Albumin, Immunoglobulins); By Method (Centrifugation, Depth Filtration); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030” in its research database.
“As per the latest research analysis, the global plasma fractionation market size/share will be valued at roughly USD 25.55 Billion in 2021, and its revenue is projected to reach about USD 45.11 Billion By 2030. The market is forecasted to expand at a compound annual growth rate of approximately 6.8% between 2022 and 2030.”
Plasma Fractionation Market: Report Overview
Plasma fractionation, as it is known in medicine, is a procedure used to separate a certain amount of a combination. Additionally, blood's fluid component, plasma, is fractionated to produce several plasma derivatives, including immunoglobulins and albumin. These plasma-derived compounds are utilized to treat various blood plasma-related diseases and have healing effects. It is also used to prevent extreme blood loss during surgical operations. Immunoglobulins are used in the treatment of primary and secondary immune deficiencies.
Moreover, patients all across the world, especially those suffering from uncommon and severe diseases, rely on plasma-derived medicines as lifesaving treatments. Additionally, as the demand for these lifesaving medications grows, continued developments in the technologies of plasma manufacture and blood plasma fractionation will guarantee that those in need will have timely access to these treatments in the foreseeable future, increasing the demand for the plasma fractionation market.
Request Sample Copy of Plasma Fractionation Market Research Report @ https://polarismarketresearch.com/industry-analysis/plasma-fractionation-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report Covers:
- 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
- 110+ Pages Research Report (Inclusion of Updated Research).
- Provide Chapter-wise guidance on Requests.
- 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures.
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Some of the Top Market Leaders Are:
- CSL
- Grifols S.A.
- Shire
- Octapharma AG
- Kedrion S.P.A
- LFB
- Biotest AG
- Sanquin
- China Biologic Products Holdings Inc.
- GC Pharma
- Bio Products Ltd.
- Japan Blood Products Organization
- Emergent BioSolutions
- Shanghai Raas Blood Products Co. Ltd.
- Intas Pharmaceuticals Ltd.
- Bharat Serum Vaccines Limited
- SK Plasma
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
- KabaFusion
- Centurion Pharma
- ADMA Biologics Inc.
- PlasmaGen BioSciences Pvt. Ltd.
- Virchow Biotech Private Limited
- Fusion Healthcare
- Hemarus Therapeutics Limited
To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://polarismarketresearch.com/industry-analysis/plasma-fractionation-market/request-for-sample
OR
Directly Purchase a copy of the report with TOC @ https://polarismarketresearch.com/buy/1473/2
Prominent Growth Driving Factors
- Increased awareness programs: Numerous awareness programs are executed to inspire people to blood donation. Also, governments and businesses are taking initiatives to raise awareness among individuals regarding the use of fractionation therapy-based products.
- Rising prevalence of infectious diseases: Globally, the prevalence of infectious diseases among the elderly population is rising, sparking extensive R&D in the field. The spread of disease and changing lifestyles are both contributing to an increase in respiratory infections. Diseases are treated using new techniques, and as technology advances, the plasma fractionation market size is anticipated to grow. Numerous treatments currently employ this fractionation technique, with encouraging results.
Top Findings of the Report
- The factors driving the market expansion are the high frequency of infectious diseases, the expanding senior population, the population of older adults who are more susceptible to infection, and the rise in blood disorders.
- The plasma fractionation market segmentation is mainly based on application, product, method, region, and end-use.
- Asia Pacific is foreseen to see the most rapid growth during the projection period.
Inquire more about this report before purchase @ https://polarismarketresearch.com/industry-analysis/plasma-fractionation-market/inquire-before-buying
(Inquire a report quote OR available discount offers to the sales team before purchase.)
Top Trends Influencing the Market
- Increased blood collection: Around the world, there are many facilities for collecting blood, and as technology advances, blood collection is rising. Also, the increasing investment in R&D in the biotechnology and pharmaceutical sectors and government initiatives are expected to boost the plasma fractionation market growth.
- Association of market players: The primary forces driving the industry's growth include partnerships between major participants in the market for creating plasma-based goods, numerous government and corporate efforts and investments, and rising R&D activity in a variety of areas.
Segmentation Analysis
Immunoglobulin Sector Accounts for the Largest Share
Due to the use of immunoglobulin products in primary and secondary immunodeficiency disorders, the immunoglobulins market category had the largest revenue share in 2021. Drug applications for immunoglobulin include delivery, immunosenescence, diagnosing metabolic diseases, treating them, and immunity-based modifications. Over the coming year, there will likely be a rise in the use of immunoglobulins due to the rising occurrence of infectious disorders.
Moreover, the market for coagulation factors is also anticipated to grow as a result of rising rates of blood donation or transplantation, increased rates of bleeding disorders, and the approval of novel medications. Major bleeding disorders, including hemophilia and von Willebrand disease, employ coagulation factors.
Centrifugation Sector Shares the Highest Revenue
Centrifugation is necessary to obtain blood supernatants of high quality. Additionally, it makes blood separation more reliable for researchers, which enhances clinical results for patients. Thus, the growing need for centrifugation equipment would support industry growth.
Also, the usage of industrial-scale chromatographic fractionation and purification techniques has increased recently. Protease inhibitors, anticoagulants, and coagulation factors are a few of the newly developed therapeutic plasma products. The development of innovative therapies for treating individuals with inherited or acquired anomalies in plasma protein levels has been made possible by chromatography. As a result, it will promote plasma fractionation market demand.
Hospitals and Clinics Sector Holds the Significant Revenue
The growing off-label usage of fractionation market items in hospitals to treat a variety of illnesses, healthcare services, and improved infrastructure are all contributing to the category's expected significant growth. A large demand for these items also results from the complex disorders that can be treated in modern therapeutic settings.
Request Customized Copy of Report @ https://polarismarketresearch.com/industry-analysis/plasma-fractionation-market/request-for-customization
(We customize your report according to your research needs. Ask our sales team for report customization.)
Geographical Overview
North America: Due to rising respiratory illnesses and public knowledge of the many benefits of plasma fractionation, the plasma fractionation market in North America currently holds the largest proportion. The existence of important players, an increase in the consumption of immunoglobulin, a rising number of blood collection facilities, and the accessibility of plasma because of the viability of plasma distribution and collections all contribute to the regional market's growth.
Asia Pacific: The plasma fractionation industry is predicted to develop in the Asia Pacific region as a result of private and public investment in R&D, rising government, favorable government regulations, increased immunoglobulin use, an aging population with blood-related disorders, and rising target disease prevalence.
Browse the Detail Report “Plasma Fractionation Market Share, Size, Trends, Industry Analysis Report, By Product (Albumin, Immunoglobulins); By Method (Centrifugation, Depth Filtration); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030” with in-depth TOC: https://polarismarketresearch.com/industry-analysis/plasma-fractionation-market
For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com
Recent Developments
- Permira released a novel immunodeficiency disorder medicine in June 2022 that uses plasma-based products for more effective and quick outcomes.
- To assist Canada in becoming self-sufficient, Grifols and Canadian Blood Services reached a deal in September 2022 to grow the immunoglobulin industry there.
The Report Answers Questions Such As
- What is the current and estimated market value of plasma fractionation during the forecast period?
- How big is the plasma fractionation market?
- What are the factors driving the market growth?
- At what CAGR rate is the market expected to grow?
- Which are the major companies dealing in the market?
- What are the key trends shaping the market?
- Which segment is holding the largest plasma fractionation market share?
Polaris Market Research has segmented the Plasma Fractionation market report based on product, application, method, end-use, and region:
By Product Outlook
- Albumin
- Immunoglobulins
- Coagulation Factors
- Protease Inhibitors
- Others
By Application Outlook
- Neurology
- Hematology
- Oncology
- Immunology
- Pulmonology
- Others
By Method Outlook
- Centrifugation
- Depth Filtration
- Chromatography
- Others
By End-Use Outlook
- Hospitals & Clinics
- Clinical Research
- Others
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com
